HIMS Latest News, Press Relases and Analysis

All

Press Releases

a day ago - By: Zacks Investment Research - Mentions: VEEV TEM

Is TEM Stock a Buy, Hold, or Sell During Its Pivotal Transition?

a day ago - By: Hims & Hers

Hims & Hers Brings Comprehensive Weight Loss Programme to the UK

2 days ago - By: Zacks Investment Research - Mentions: TDOC GDRX

Hims & Hers Plunges 29.1% in 6 Months: Time to Hold the Stock or Sell?

3 days ago - By: Zacks Investment Research - Mentions: OMCL

OMCL vs. HIMS: Which Stock Should Value Investors Buy Now?

6 days ago - By: Zacks Investment Research - Mentions: MED TEM

Tempus AI Boosts Its Clinical AI Capabilities Through Strategic Moves

7 days ago - By: Zacks Investment Research - Mentions: ISRG IDXX SOLV

HIMS Stock Jumps After Buyout Deal, Boosts Blood Collection Efficiency

7 days ago - By: Hims & Hers

Hims & Hers Continues Major International Expansion With Official Entry Into Canada

21 days ago - By: Zacks Investment Research - Mentions: OMCL

OMCL or HIMS: Which Is the Better Value Stock Right Now?

24 days ago - By: Benzinga

What's Going On With Hims & Hers Health Shares Monday?

8 days ago - By: Zacks Investment Research - Mentions: OMCL

Hims & Hers Health (HIMS) Down 15.1% Since Last Earnings Report: Can It Rebound?

8 days ago - By: Zacks Investment Research - Mentions: AMWL LFMD

Hims & Hers Expands Care Scope as Prescription Platforms Evolve

8 days ago - By: Hims & Hers

Hims & Hers to Acquire YourBio Health, Pioneer Behind Advanced, Pain-Free Blood Sampling Technology

10 days ago - By: Zacks Investment Research

Here is What to Know Beyond Why Hims & Hers Health, Inc. (HIMS) is a Trending Stock

13 days ago - By: Zacks Investment Research - Mentions: GDRX

HIMS vs. GDRX: Which Consumer Health Stock Offers Greater Upside?

15 days ago - By: The Motley Fool

Why Is Hims & Hers Stock Falling, and Should Investors Buy the Dip?

15 days ago - By: Stocktwits - Mentions: NVO LLY VKTX HSBC ...

Retail Traders Crown Novo Nordisk As Long-Term Weight Loss King — Even As Eli Lilly Hits $1T And Viking Fans Tout ‘M&A Prize’

16 days ago - By: Zacks Investment Research - Mentions: MED TEM

Hims & Hers Expands Care Scope as Digital Health Platforms Evolve

20 days ago - By: Zacks Investment Research - Mentions: GDRX DOCS

Hims & Hers Accelerates Its Clinician-Led, Platform-Driven Care Model

23 days ago - By: Zacks Investment Research - Mentions: TDOC AMWL

Hims & Hers Plunges 15.6% in 3 Months: Time to Hold the Stock or Sell?

23 days ago - By: Zacks Investment Research

Is Trending Stock Hims & Hers Health, Inc. (HIMS) a Buy Now?

24 days ago - By: Benzinga - Mentions: NVDA ORCL SMCI CMG ...

Ready For A Rebound? Here Are 10 Oversold Stocks To Watch

24 days ago - By: Stocktwits

Hims & Hers Announces New $250 Million Share Repurchase Program – Retail Sees A Steady Trading Range For The Stock

24 days ago - By: Hims & Hers

Hims & Hers Health, Inc. Announces $250 Million Share Repurchase Program Authorization